Ophthalmic Comprehensive Reports

2018 Glaucoma Pharmaceuticals Report: A Global Market Analysis for 2017 to 2023, June, 2018

Market Scope’s 2018 Glaucoma Pharmaceuticals Report features new and updated estimates of glaucoma populations around the world; analysis of two new classes of glaucoma therapeutics launched in the US in 2018: nitric oxide-donating compounds and rho kinase (ROCK) inhibitors; and expanded discussions of genetics, gene therapies, stem cell therapies, and sustained-release devices.

Want to Purchase the Full Report?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email: info@market-scope.com

©2019 Market Scope, LLC. All Rights reserved.